Overview

Endothelial Dysfunction in Resuscitated Cardiac Arrest

Status:
Completed
Trial end date:
2017-02-27
Target enrollment:
Participant gender:
Summary
Objective: Safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac-arrest-syndrome (PCAS) patients.
Phase:
Phase 2
Details
Lead Sponsor:
Pär Johansson
Treatments:
Epoprostenol
Iloprost
Tezosentan